February 5, 2019 Rajat Rai RE: Separation and Consulting Agreement Dear Raj:Separation and Consulting Agreement • March 1st, 2019 • Akorn Inc • Pharmaceutical preparations
This Separation and Consulting Agreement (this “Agreement”) is intended to set forth our mutual understanding and agreement regarding your retirement as Chief Executive Officer and from your employment with Akorn, Inc., a Louisiana corporation (collectively with its successors and assigns, the “Company”), and all its affiliates, as the parties agreed to formalize such understandings in the letter agreement entered into between the parties December 27, 2018 and as disclosed in the Company’s filings with the SEC on Form 8-K.
February 4, 2019 Bruce Kutinsky RE: Separation and Consulting Agreement Dear Bruce:Separation and Consulting Agreement • March 1st, 2019 • Akorn Inc • Pharmaceutical preparations
This Separation and Consulting Agreement (this “Agreement”) is intended to set forth our mutual understanding and agreement regarding your termination as Chief Operating Officer and your employment with Akorn, Inc., a Louisiana corporation (collectively with its successors and assigns, the “Company”), and all its affiliates, as the parties agreed to formalize such understandings in the letter agreement entered into between the parties January 7, 2019 and as disclosed in the Company’s filings with the SEC on Form 8-K.
AMENDMENT #1 TO EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2019 • Akorn Inc • Pharmaceutical preparations
This Amendment (this “Amendment”) is made and entered into effective as of December 31, 2018 (“Effective Date”), by and between Rajat Rai (“Rai”), and Akorn, Inc., a Louisiana corporation (the "Company"). Rai and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
